ES8601141A1 - Un procedimiento para la produccion de derivados de isoquinolina sustituidos - Google Patents

Un procedimiento para la produccion de derivados de isoquinolina sustituidos

Info

Publication number
ES8601141A1
ES8601141A1 ES532603A ES532603A ES8601141A1 ES 8601141 A1 ES8601141 A1 ES 8601141A1 ES 532603 A ES532603 A ES 532603A ES 532603 A ES532603 A ES 532603A ES 8601141 A1 ES8601141 A1 ES 8601141A1
Authority
ES
Spain
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
isoquinoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532603A
Other languages
English (en)
Other versions
ES532603A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES532603A0 publication Critical patent/ES532603A0/es
Publication of ES8601141A1 publication Critical patent/ES8601141A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ISOQUINOLINA Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES DE FORMULA (I) EN LA QUE R ES ALCOXILO INFERIOR; A PUEDE SER UNO DE VARIOS TIPOS DE RADICALES; Y N VALE 0 O 1. CONSISTE EN LA REACCION DE CONDENSACION DE UN COMPUESTO DE FORMULA (II) CON UNA AMINA DE FORMULA HA EN LAS QUE HAL ES HALOGENO A PUEDE SER UNO DE VARIOS RADICALES Y R Y N TIENEN LOS MISMOS SIGNIFICADOS QUE EN LA FORMULA (I). LA CONDENSACION TIENE LUGAR EN UN DISOLVENTE INERTE EN PRESENCIA DE UNA BASE A UNA TEMPERATURA COMPRENDIDA ENTRE LA AMBIENTE Y 100JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO Y CONTROL DE LOS TRASTORNOS CEREBROVASCULARES.
ES532603A 1983-05-19 1984-05-18 Un procedimiento para la produccion de derivados de isoquinolina sustituidos Expired ES8601141A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,327 US4544657A (en) 1983-05-19 1983-05-19 Substituted isoquinolines

Publications (2)

Publication Number Publication Date
ES532603A0 ES532603A0 (es) 1985-11-01
ES8601141A1 true ES8601141A1 (es) 1985-11-01

Family

ID=23972146

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532603A Expired ES8601141A1 (es) 1983-05-19 1984-05-18 Un procedimiento para la produccion de derivados de isoquinolina sustituidos

Country Status (20)

Country Link
US (1) US4544657A (es)
EP (1) EP0126480B1 (es)
JP (1) JPS59222478A (es)
KR (1) KR840009102A (es)
AT (1) ATE32072T1 (es)
AU (1) AU570044B2 (es)
CA (1) CA1243028A (es)
DE (1) DE3468875D1 (es)
DK (1) DK248484A (es)
ES (1) ES8601141A1 (es)
FI (1) FI81795C (es)
GR (1) GR82015B (es)
HU (1) HU192555B (es)
IL (1) IL71860A (es)
MC (1) MC1597A1 (es)
NO (1) NO159271C (es)
NZ (1) NZ208186A (es)
PH (1) PH19670A (es)
PT (1) PT78618A (es)
ZA (1) ZA843748B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2616937A1 (en) 2005-07-29 2007-02-08 F. Hoffman-La Roche Ag Indol-3-yl-carbonyl-piperidin and piperazin derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759443A (fr) * 1970-09-15 1971-04-30 I F L O Istituto Farmacologico Nouveau derive papaverolinique et procede de preparation relatif
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung
ZA803992B (en) * 1979-07-19 1981-06-24 Buzas Andre New papaverine carbanion and its preparation
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
FI81795C (fi) 1990-12-10
DK248484A (da) 1984-11-20
FI81795B (fi) 1990-08-31
DE3468875D1 (en) 1988-02-25
GR82015B (es) 1984-12-12
ES532603A0 (es) 1985-11-01
HU192555B (en) 1987-06-29
NO842003L (no) 1984-11-20
US4544657A (en) 1985-10-01
MC1597A1 (fr) 1985-05-09
IL71860A (en) 1987-10-30
FI841992A0 (fi) 1984-05-17
PH19670A (en) 1986-06-09
ZA843748B (en) 1985-01-30
JPS59222478A (ja) 1984-12-14
IL71860A0 (en) 1984-09-30
CA1243028A (en) 1988-10-11
NZ208186A (en) 1987-06-30
NO159271B (no) 1988-09-05
HUT34185A (en) 1985-02-28
DK248484D0 (da) 1984-05-17
PT78618A (en) 1984-06-01
FI841992A (fi) 1984-11-20
ATE32072T1 (de) 1988-02-15
AU570044B2 (en) 1988-03-03
EP0126480A1 (de) 1984-11-28
KR840009102A (ko) 1984-12-24
EP0126480B1 (de) 1988-01-20
NO159271C (no) 1988-12-14
AU2835684A (en) 1984-11-22

Similar Documents

Publication Publication Date Title
IT1182150B (it) Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono
BG98793A (en) Animoacid derivatives, method for their preparation and pharmaceutical composition containing them
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
MY101721A (en) 6-vinyl-furo-(3,4-c)-pyridine derivatives
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
PH20327A (en) New substituted 1,4-dihydropyridines and pharmaceutical compositions containing the same
ES8800679A1 (es) Un procedimiento para preparar derivados de piperiliden-dihidrodibenzo-(a,d)-cicloheptenos y derivados aza
FI92069C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1H,3H-pyrrolo/1,2-c/tiatsoli-7-karboksamidijohdannaisten valmistamiseksi
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
ES8600261A1 (es) Un compuesto fenoxi
ES8601141A1 (es) Un procedimiento para la produccion de derivados de isoquinolina sustituidos
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
IE893956L (en) Novel compounds
PT84814A (en) 3-hydroxypyridines
ES8604146A1 (es) Procedimiento de preparacion de nuevos derivados de piperidina y sus sales de adicion acidas y amonicas cuaternarias
ZA842686B (en) Disubstituted polymethylene imines,processes for the preparation thereof and pharmaceutical compositions containing them
DE3264556D1 (en) Sulfimines, their salts and their preparation, and pharmaceutical compositions containing them
ES8605269A1 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central
GB8515212D0 (en) Thiazolidine derivatives
HUT45059A (en) Process for producing abeoergoline derivatives
NZ222973A (en) Substituted piperidine and azepine derivatives and pharmaceutical compositions
NO942051L (no) Nye tiosemikarbazontioner
ES8401943A1 (es) Procedimiento para la preparacion de derivados de 2-piridona.
SE8405338D0 (sv) (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas